Search

Donald H Schlafer

from Alpine, NY
Age ~76
Get Report
Also known as:
Donald A Schlafer
Phone and address:
4235 Shuler Rd, Alpine, NY 14805
(607) 387-9517
Related to:
Michelle L Schlafer, 52Nathan Schlafer, 39Judith Appleton, 71Russell Schlafer, 36
Connected to:
Dan P Schlaffman, 72Janice M Schlaffer, 77Kathryn A Schlafge, 73Margie Schlaff, 97Mysti C Schlafer, 39Wayne H Schlafer, 83Benjamin L Schlafke, 69Valerie A Schlafke, 68Aaron H Schlafly, 52Cathryn H Schlafley, 64

Donald Schlafer Phones & Addresses

  • 4235 Shuler Rd, Alpine, NY 14805 (607) 387-9517
  • Hector, NY
  • Guilford, NY
  • 4235 Shuler Rd, Alpine, NY 14805

Work

Position: Sales Occupations

Education

Degree: High school graduate or higher

Emails

d***[email protected]

Professional Records

License Records

Donald Hughes Schlafer

Address:
4235 Shuler Rd, Alpine, NY 14805
License #:
A3330594
Category:
Airmen

Business Records

Name / Title
Company / Classification
Phones & Addresses
Donald Schlafer
Principal
Schlafer
Business Services at Non-Commercial Site
4235 Shuler Rd, Alpine, NY 14805

Publications

Us Patents

Methods Of Minimizing Immunological Rejection Of A Nuclear Transfer Fetus

View page
US Patent:
20100016654, Jan 21, 2010
Filed:
May 19, 2009
Appl. No.:
12/468208
Inventors:
Christopher J. DAVIES - Logan UT, US
Donald H. SCHLAFER - Alpine NY, US
Jonathan R. HILL - New South Wales, AU
Assignee:
CORNELL RESEARCH FOUNDATION, INC - Ithaca NY
International Classification:
A61B 17/435
US Classification:
600 34
Abstract:
The present invention relates to a method of minimizing immunological rejection of a nuclear transfer (“NT”) fetus which includes transferring a NT embryo into an embryo recipient under conditions effective for development of a NT fetus with minimal risk of immunological rejection of the fetus due to a maternal anti-fetal MHC-I immune response. After determining an MHC-I antigen type for a NT embryo and an MHC-I antigen type for embryo recipients, the NT embryo is either (i) transferred into a first embryo recipient having a compatible MHC-I antigen type under conditions effective for development of a NT fetus from the NT embryo, or (ii) transferred into a second embryo recipient having an incompatible MHC-I antigen type, followed by regulating MHC-I expression of the NT embryo or suppressing an immune response of the embryo recipient under conditions effective for development of a nuclear transfer fetus.

Methods Of Minimizing Immunological Rejection Of A Nuclear Transfer Fetus

View page
US Patent:
20040029825, Feb 12, 2004
Filed:
Jul 28, 2003
Appl. No.:
10/398308
Inventors:
Christopher Davies - Pullman WA, US
Donald Schlafer - Alpine NY, US
Jonathan HIll - New South Wales, AU
International Classification:
A61K048/00
US Classification:
514/044000, 800/021000
Abstract:
The present invention relates to a method of minimizing immunological rejection of a nuclear transfer (“NT”) fetus which includes transferring a NT embryo into an embryo recipient under conditions effective for development of a NT fetus with minimal risk of immunological rejection of the fetus due to a maternal anti-fetal MHC-I immune response. After determining an MHC-I antigen type for a NT embryo and an MHC-I antigen type for embryo recipients, the NT embryo is either (i) transferred into a first embryo recipient having a compatible MHC-I antigen type under conditions effective for development of a NT fetus from the NT embryo, or (ii) transferred into a second embryo recipient having an incompatible MHC-I antigen type, followed by regulating MHC-I expression of the NT embryo or suppressing an immune response of the embryo recipient under conditions effective for development of a nuclear transfer fetus.
Control profile
Donald H Schlafer from Alpine, NY, age ~76 Get Report